Merck to Acquire Remaining 49% of Banyu for US$1.52 B
By Business Review Editor
Pharma Deals Review: Vol 2003 Issue 32 (Table of Contents)
Published: 3 Jan-2003
DOI: 10.3833/pdr.v2003.i32.957 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Merck & Co plans to launch a tender offer for the remaining 49% of Banyu Pharmaceutical shares for US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018